<DOC>
	<DOCNO>NCT02303093</DOCNO>
	<brief_summary>Non-Interventional Study Tolerability Efficacy octagam® 10 %</brief_summary>
	<brief_title>Non-Interventional Octagam® 10 % - GAM10-06 `` GammaTrack ''</brief_title>
	<detailed_description>A Non-Interventional Study Tolerability Efficacy octagam® 10 % . Patients indication ( replacement immonomodulation ) describe treat physician . Marketed Octagam 5 % 10 % use accord investigator prescription ; intravenous ( iv ) administration.The primary objective detect evaluate adverse drug reaction ( ADRs ) occur administration Octagam indication , age group treatment regimen , causal relationship administration Octagam suspect .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>Any patient need treat product class his/her medical condition treat physician decides prescribe Octagam regularly , may include .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>